Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMAZEPAM Cause Contraindicated product administered? 300 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 300 reports of Contraindicated product administered have been filed in association with TEMAZEPAM (Temazepam). This represents 5.2% of all adverse event reports for TEMAZEPAM.

300
Reports of Contraindicated product administered with TEMAZEPAM
5.2%
of all TEMAZEPAM reports
109
Deaths
11
Hospitalizations

How Dangerous Is Contraindicated product administered From TEMAZEPAM?

Of the 300 reports, 109 (36.3%) resulted in death, 11 (3.7%) required hospitalization, and 7 (2.3%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMAZEPAM. However, 300 reports have been filed with the FAERS database.

What Other Side Effects Does TEMAZEPAM Cause?

Toxicity to various agents (1,583) Completed suicide (840) Overdose (759) Drug ineffective (733) Drug abuse (626) Pain (558) Headache (544) Off label use (534) Hyperhidrosis (486) Hypersensitivity (479)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which TEMAZEPAM Alternatives Have Lower Contraindicated product administered Risk?

TEMAZEPAM vs TEMODAR TEMAZEPAM vs TEMOZOLOMIDE TEMAZEPAM vs TEMSIROLIMUS TEMAZEPAM vs TENAMFETAMINE TEMAZEPAM vs TENAPANOR

Related Pages

TEMAZEPAM Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered TEMAZEPAM Demographics